Skip to main content

Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial

Access & Citations

  • 2771
    Article Accesses
  • 0
    Web of Science
  • 0
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.